Literature DB >> 22278008

[Management and therapy of atrial fibrillation in geriatric patients].

M Gosch1, R E Roller, B Böhmdorfer, U Benvenuti-Falger, B Iglseder, M Lechleitner, U Sommeregger, P Dovjak.   

Abstract

Among geriatric patients, atrial fibrillation is the most common cardiac arrhythmia. In patients over 80 years of age, the prevalence rises to approximately 10%. Atrial fibrillation is associated with serious health implications, including a 2-fold increase in mortality risk and a 5-fold increase in stroke risk. In contrast to these facts, the current guidelines on the management of atrial fibrillation of the European Society of Cardiology (ESC) contain only a short paragraph on these patients. Many relevant clinical aspects go without any comment. Thus, the purpose of our paper is to discuss those special needs of geriatric patients and their physicians which are not mentioned in the guidelines of the ESC. In our review, we discuss rhythm versus rate control, oral anticoagulation, outcome, prevention, falls, adherence, polypharmacy, dementia, nursing home patients, frailty, and geriatric assessment in consideration of geriatric patients. An extended search of the literature on Pubmed served as the basis for this review. Individual aspects of each geriatric patient should be considered when managing these complex patients; however, the complexity of each case must not lead to an individualized therapy that is not in accordance with current guidelines and the literature. A large number of papers which help us to answer most of the clinical questions regarding the management of trial fibrillation in geriatric patients have already been published.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22278008     DOI: 10.1007/s00391-011-0268-0

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  57 in total

Review 1.  Problems of nonadherence in cardiology and proposals to improve outcomes.

Authors:  John B Garner
Journal:  Am J Cardiol       Date:  2010-05-15       Impact factor: 2.778

2.  Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall.

Authors:  Brian F Gage; Elena Birman-Deych; Roger Kerzner; Martha J Radford; David S Nilasena; Michael W Rich
Journal:  Am J Med       Date:  2005-06       Impact factor: 4.965

3.  The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens.

Authors:  Jeffrey J Glasheen; Randolph V Fugit; Allan V Prochazka
Journal:  J Gen Intern Med       Date:  2005-07       Impact factor: 5.128

Review 4.  Quality of life in patients with atrial fibrillation: a systematic review.

Authors:  Graham Thrall; Deirdre Lane; Douglas Carroll; Gregory Y H Lip
Journal:  Am J Med       Date:  2006-05       Impact factor: 4.965

5.  A team-based approach to warfarin management in long term care: a feasibility study of the MEDeINR electronic decision support system.

Authors:  Alexandra Papaioannou; Courtney C Kennedy; Glenda Campbell; Jacqueline B Stroud; Luqi Wang; Lisa Dolovich; Mark A Crowther
Journal:  BMC Geriatr       Date:  2010-06-10       Impact factor: 3.921

Review 6.  Meta-analysis of the impact of 9 medication classes on falls in elderly persons.

Authors:  John C Woolcott; Kathryn J Richardson; Matthew O Wiens; Bhavini Patel; Judith Marin; Karim M Khan; Carlo A Marra
Journal:  Arch Intern Med       Date:  2009-11-23

7.  Risk factors for nonadherence to warfarin: results from the IN-RANGE study.

Authors:  Alec B Platt; A Russell Localio; Colleen M Brensinger; Dean G Cruess; Jason D Christie; Robert Gross; Catherine S Parker; Maureen Price; Joshua P Metlay; Abigail Cohen; Craig W Newcomb; Brian L Strom; Mitchell S Laskin; Stephen E Kimmel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-09       Impact factor: 2.890

8.  Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

Authors:  Laurie G Jacobs; Henny H Billett; Katherine Freeman; Cheryl Dinglas; Lynette Jumaquio
Journal:  Am J Geriatr Pharmacother       Date:  2009-06

9.  STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.

Authors:  P Gallagher; C Ryan; S Byrne; J Kennedy; D O'Mahony
Journal:  Int J Clin Pharmacol Ther       Date:  2008-02       Impact factor: 1.366

10.  Short- and long-term prognosis for very old stroke patients. The Copenhagen Stroke Study.

Authors:  Lars Peter Kammersgaard; H S Jørgensen; J Reith; H Nakayama; P M Pedersen; T S Olsen
Journal:  Age Ageing       Date:  2004-03       Impact factor: 10.668

View more
  3 in total

1.  [Digitalis and theophylline: old and superfluous?].

Authors:  M Gosch; P Dovjak
Journal:  Z Gerontol Geriatr       Date:  2013-07       Impact factor: 1.281

2.  [Tools for optimizing pharmacotherapy for geriatric patients with multimorbidity at the end of life: helpful oder just raising awareness?].

Authors:  Renate Riesinger; Bernhard Iglseder
Journal:  Wien Med Wochenschr       Date:  2014-04-09

3.  [Falls and dementia are not contraindications for anticoagulation in older adults with atrial fibrillation].

Authors:  M Gosch; B Iglseder; H J Heppner
Journal:  Z Gerontol Geriatr       Date:  2016-07       Impact factor: 1.281

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.